Delivery Order SPE2DB20D1100-SPE2DB24FZ08U
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,106.36 firm-fixed-price delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to support military healthcare programs. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The $4,389.43 firm fixed price contract is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of July 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $17,374.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to support military healthcare programs. The contract has an ultimate completion date of November 9, 2023, and is a firm fixed-price delivery order. The contract was awarded through full and open competition, with no set-aside designation....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,674.09 firm-fixed-price delivery order is for the pharmaceutical product Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract has an ultimate completion date of November 20, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The Delivery Order contract, valued at $3,870.01, is for the procurement of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract has an ultimate completion date of December 7, 2023 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The $4,609.06 firm fixed-price delivery order has a completion date of December 5, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The fixed-price delivery order, valued at $1,451.35, has a completion date of June 6, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award, valued at $8,356.05, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. This is a firm fixed-price delivery order contract with a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $5,739.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product, with a completion date of December 29, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. The contract was awarded on an open competition basis, with no set-aside designation. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceutical products. The contract has a ceiling value of $5,731.09 and an ultimate completion date of December 1, 2023. The contract is a delivery order under a firm fixed-price pricing type, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FZ08UDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,612.34 firm fixed-price delivery order is for the procurement of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract has an ultimate completion date of December 5, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award falls under that broader IDC. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/4/23 |